✦ LIBER ✦

Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1

✍ Scribed by Manns, Michael P. ;Poordad, Fred ;Bacon, Bruce R. ;Bruno, Savino ;Esteban, Rafael ;Silva, Marcelo O. ;Buti, Maria ;Burroughs, Margaret ;Sniukiene, Vilma ;Boparai, Navdeep ;Brass, Clifford A. ;Albrecht, Janice K. ;Bronowicki, Jean-Pierre

Book ID: 123592510
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 258 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63907-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

448 RESPONSE-GUIDED THERAPY WITH BOCEPRE

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Four-Week Therapy With Peginterferon Alf

Four-Week Therapy With Peginterferon Alfa-2B/Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-NaïVE and Previous-Treatment-Failure Patients With HCV-1 Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Vierling, John M. ;Lawitz, Eric J. ;Poordad, Fred ;Sulkowski, Mark ;Bourliere, M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 431 KB

481 FOUR-WEEK THERAPY WITH PEGINTERFERON

481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ J.M. Vierling; E.J. Lawitz; F. Poordad; M.S. Sulkowski; M. Bourliere; M. Buti; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Efficacy Among North American and Europe

Efficacy Among North American and European HCV Genotype-1 Treatment-NaïVE and Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Marcellin, Patrick ;Vierling, John M. ;Alric, Laurent ;Pirisi, Mario ;Tran, Albe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 364 KB

452 EFFICACY AMONG NORTH AMERICAN AND EU

452 EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ P. Marcellin; J.M. Vierling; L. Alric; M. Pirisi; A. Tran; J.K. Albrecht; C.A. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Adherence to Assigned Dosing Regimen and

Adherence to Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C Genotype 1 Treatment-NaïVE and PEG/Ribavirin Treatment-Failures Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

✍ Gordon, Stuart C. ;Lawitz, Eric J. ;Bacon, Bruce R. ;Sulkowski, Mark ;Yoshida, E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB